Greater care should be taken to report IOL problems

Article

Surgeons should take greater precaution when compiling patient safety incidence (PSI) reports for cataract surgical care.

A study published in Eye has proposed surgeons should take greater precaution when compiling patient safety incidence (PSI) reports for cataract surgical care.

Dr S. P. Kelly et al., Royal Bolton Hospital NHS Foundation Trust, Lancashire, UK, identified 164 PSI reports of incorrect IOL implantation in NHS care in England and Wales between 2003 and 2010. The information was gathered from the National Patient Safety Agency.

Of the patients involved in the study, 47 required further surgical intervention, 163 patients needed IOL exchange surgery and 62 reports didn't name any reason for wrong IOL implantation.

The casual reasons for cataract surgery error included inaccurate biometry, wrong IOL selection, transcription errors and handwriting misinterpretations. It was suggested that ophthalmic teams to consider these reasons in order to improve their practice.

IOL implant errors occur infrequently but it was found that they are a threat to quality of cataract care. The study suggests greater attention should be given when creating PSI reports.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.